Detalles de la búsqueda
1.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Cancer
; 125(22): 3974-3984, 2019 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318460
2.
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
; 22(4): 803-816, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30706247
3.
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(6): 732-742, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526536
4.
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
Lancet Oncol
; 18(6): 743-754, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526538
5.
Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.
Br J Clin Pharmacol
; 83(12): 2767-2777, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733983
6.
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Circulation
; 110(13): 1780-6, 2004 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-15381643
7.
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
J Clin Oncol
; 33(32): 3733-40, 2015 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324362
8.
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Clin Cancer Res
; 21(19): 4305-11, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041745
9.
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
Eur J Heart Fail
; 6(3): 343-50, 2004 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14987586
10.
Course of HIV disease does not depend on risk group: 7.5-year follow-up in 296 patients.
Int J STD AIDS
; 14(7): 451-7, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12869224
Resultados
1 -
10
de 10
1
Próxima >
>>